FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for dihydroergotamine mesylate submitted by Oceanside Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

SUPPL AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)